Amplifi Vascular, Inc. has developed the Amplifi™ Vein Dilation System, a specialized device designed to enhance the size of veins in patients preparing for arteriovenous fistula (AVF) surgery. This system utilizes a proprietary blood pump technology that consists of a wearable external pump, inflow and outflow catheters, and a rechargeable battery-operated controller. The primary goal of the Amplifi Vein Dilation System is to increase the eligibility of patients for AVF surgery, expedite the maturation process of the AVF, reduce the likelihood of AVF failure, and ultimately prolong the primary patency of the AVF.

The technology works by rapidly dilating and preparing the vein using established hemodynamic principles, and it is designed to be removed prior to the actual creation of the AVF. By increasing the diameter of veins, the system aims to improve blood flow, which is crucial for the successful use of AVF in hemodialysis patients. This innovation is particularly significant for patients with smaller veins, who may otherwise be at a higher risk of AVF maturation failure. The Amplifi Vein Dilation System is currently under development and is not yet available for commercial sale, but it holds promise for providing reliable vascular access for patients requiring hemodialysis.

United States

Amplifi Vascular is developing the Amplifi™ Vein Dilation System, a wearable, external blood pump designed to enlarge veins using proprietary technology. This system aims to increase eligibility for arteriovenous fistula (AVF) surgery, accelerate AVF maturation, reduce AVF failures, and prolong primary patency. By rapidly dilating and preparing veins prior to AVF creation, the device seeks to provide sustained and reliable vascular access for hemodialysis patients. As of now, the Amplifi Vein Dilation System is under development and not available for sale.

Amplifi Vascular, Inc.

Company Details